The High Efficiency of AutoSCT in the Treatment of Refractory Follicular Lymphoma (FL): Results of the First Russian Prospective Study

FL represents one of the most frequent type of lymphomas: about 22% of non-Hodgkin lymphomas in Russia. 20% of patients (pts) are refractory to conventional R-CHOP therapy with dismal outcome. In cases with progressive tumor on induction therapy, autoSCT allows to increase the overall (OS) and progression-free survival (PFS).
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research